77 results
DEF 14A
IMCR
Immunocore Holdings plc
12 Apr 24
Definitive proxy
4:20pm
is present, an ordinary resolution is passed if it is approved by holders representing a simple majority of the total voting rights of shareholders present … by holders representing a simple majority of the total voting rights of shareholders present (in person or by proxy) who are entitled to vote and vote
8-K
EX-5.1
IMCR
Immunocore Holdings plc
5 Apr 24
Other Events
4:35pm
Directors to vote), a quorum was present throughout, the requisite majority of Directors voted in favour of approving the resolutions and the resolutions
424B7
IMCR
Immunocore Holdings plc
5 Apr 24
Prospectus with selling stockholder info
4:34pm
remove a director without cause by an ordinary resolution (which is passed by a simple majority of those voting in person or by proxy at a general … of directors may be removed, with or without cause, by the holders of a majority of the shares then entitled to vote at an election of directors
PRE 14A
IMCR
Immunocore Holdings plc
2 Apr 24
Preliminary proxy
4:45pm
a simple majority of the total voting rights of shareholders present (in person or by proxy) who (being entitled to vote) vote on the resolution … if it is approved by holders representing a simple majority of the total voting rights of shareholders present (in person or by proxy) who
S-8
EX-5.1
IMCR
Immunocore Holdings plc
20 Mar 24
Registration of securities for employees
8:55pm
was and/or will be present throughout, the requisite majority of Directors voted and/or will vote in favour of approving the resolutions and the resolutions passed
S-3ASR
8r05ue4pa5 47p
20 Mar 24
Automatic shelf registration
8:51pm
S-3ASR
EX-5.2
v6kks9
20 Mar 24
Automatic shelf registration
8:51pm
S-3ASR
EX-5.1
ysjq3rlvete4bphe
20 Mar 24
Automatic shelf registration
8:51pm
10-K
EX-97.1
iixgjub
28 Feb 24
Annual report
7:33am
10-K
4x2z49r3o 749tend06
28 Feb 24
Annual report
7:33am
8-K
EX-4.1
inlwcbi
2 Feb 24
Immunocore Prices Upsized Convertible Senior Notes Offering
4:05pm
8-K
EX-99.2
lz2qwr0x90 lii8
5 Jan 24
Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentation
7:19am
6-K
EX-99.2
fqz3k0 7oa61i
7 Nov 23
Current report (foreign)
7:09am
6-K
EX-99.1
ikq8zfwvg5keojccy72
7 Nov 23
Current report (foreign)
7:09am
6-K
EX-99.1
8s9efihgz8mvw 3wh4
10 Aug 23
Current report (foreign)
8:28am
6-K
EX-99.2
3s1hhyaah5fbi0s nn
10 Aug 23
Current report (foreign)
8:28am
6-K
EX-99.2
4f9e2
10 May 23
Current report (foreign)
7:27am
6-K
EX-99.3
4d1hpcwomu94kkd60y
10 May 23
Current report (foreign)
7:27am
S-8
EX-5.1
kffxf j65cx
6 Apr 23
Registration of securities for employees
4:24pm
6-K
d5btc
8 Dec 22
Immunocore presents ovarian cancer expansion data for ImmTAC® candidate IMC-C103C targeting MAGE-A4
4:59pm